obesity drug news today glp-1 october 21 2025 Market New oral GLP-1 drugs could

We cant talk about the gut without mentioning the trillions of microbes living inside you

This is a trend weve been seeing and its been seen by other studies as well that theres a shortage of these medications because its a much broader indication now than just diabetics its patients who are obese and dont have diabetes can get these medications, he told us

Rakovic A, Grnewald A, Seibler P, Ramirez A, Kock N, Orolicki S, et al

During the healing process of acute wounds, the local macrophage population changes from being mostly pro-inflammatory (M1) to anti-inflammatory (M2)

Some patients ask about peptide therapy as part of a broader wellness plan focused on energy, vitality, and daily performance